VERAXA Biotech press releases
The latest press releases from VERAXA Biotech (NASDAQ: VRXA), gathered from its own newsroom and from the newswires that carry it. PPN World follows 1,400+ press release feeds and adds each VERAXA Biotech release within minutes of publication.
- Listing
- NASDAQ: VRXA
- Latest release
- Oct 21, 2026
- On this page
- 20 newest releases
Latest VERAXA Biotech press releases
- VERAXA Biotech (VRXA) Expands Human-Relevant Testing Strategy to Advance Antibody-Based Cancer Pipeline
VERAXA is implementing FDA-aligned New Approach Methodologies (“NAMs”) across its preclinical research programs, aiming to improve the relevance of experimental findings to human biology while reducin…
- VERAXA Biotech (NASDAQ: VRXA) Expands Human-Relevant Testing Strategy to Advance Antibody-Based Cancer Pipeline
Austin, Texas, United States, 21st October 2026, NewsDirect
- VERAXA Biotech (VRXA) Presents First In Vivo Proof-of-Concept Data for BiTAC-ADC Platform at World ADC Congress
LOS ANGELES, CA - October 13, 2026 ( NEWMEDIAWIRE ) - VERAXA Biotech (NASDAQ: VRXA) , an emerging leader in designing novel cancer therapies, presented its first in vivo proof-of-concept data and addi…
The first 3 are open to everyone. A free account shows the rest and emails you the next VERAXA Biotech release the minute it is out.
PPN World is independent and not affiliated with VERAXA Biotech. Headlines and short excerpts only; each release links to its source.
Questions
Where can I find VERAXA Biotech press releases?+
How do I get an alert when VERAXA Biotech publishes a press release?+
Is this VERAXA Biotech's official newsroom?+
Know the minute VERAXA Biotech publishes
Watch VERAXA Biotech, its competitors and its sector in one live feed, with email alerts — on the free plan.